Treatment of Attention Deficit Hyperactivity Disorder in Children and AdolescentsSafety Considerations

被引：0
作者：
Mark L. Wolraich
Laura McGuinn
Melissa Doffing
机构：
[1] University of Oklahoma Health Sciences Center,Department of Pediatrics, Section of Developmental and Behavioral Pediatrics
来源：
Drug Safety | 2007年 / 30卷
关键词：
Attention Deficit Hyperactivity Disorder; Sudden Cardiac Death; Methylphenidate; Attention Deficit Hyperactivity Disorder; Atomoxetine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Despite a large body of evidence for both the validity of the diagnosis of attention deficit hyperactivity disorder (ADHD) and the efficacy of its treatment with medication, there is an equally long history of controversy. This article focuses on presenting safety information for medications approved by the US FDA for the treatment of individuals with ADHD.
引用
收藏
页码：17 / 26
页数：9
相关论文
共 141 条
[21]  
Danckaerts M(2002)Attention deficit/hyperactivity disorder and methylphenidate: A review of height/weight, cardiovascular, and somatic complaint side effects Clin Psychol Rev 22 1107-7
[22]  
Gillberg C(1988)A survey of medication treatment for hyperactive/inattentive students JAMA 260 2256-8
[23]  
Michelson D(1992)Effect of a media blitz and a threatened lawsuit on stimulant treatment JAMA 268 1004-30
[24]  
Allen A(1996)Increased methylphenidate usage for attention deficit disorder in the 1990’s Pediatrics 98 1084-41
[25]  
Busner J(2000)Trends in the prescribing of psychotropic medications to preschoolers JAMA 283 1025-41
[26]  
Pliszka SR(2003)Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder Paediatric Drugs 5 833-92
[27]  
Wolraich M(2005)Dexmethylphenidate extended-release capsules for attention deficit hyperactivity disorder Expert Rev Neurother 5 437-501
[28]  
Varley C(2001)Randomized controlled trial of OROS methylphenidate once a day in children with attention-deficit/hyperactivity disorder Pediatrics 108 883-54
[29]  
McClellan J(1987)Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder Pediatrics 80 491-85
[30]  
Greenhill LL(2004)A double-blind, placebo-controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder J Child Adolesc Psychopharmacol 14 542-51
12345678910